Document is current
Any future updates will be listed below
-
Authors
An, Tao
Han, Han
Xie, Junying
Wang, Yifan
Zhao, Yiqi
Jia, Hao
Wang, Yanfeng
-
Funding
Funding for this research was provided by:
the National Natural Science Fundation of China (823B2007)
the CAMS Innovation Fund for Medical Sciences (2022-I2M-C&T-B-069)
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2020A17)
- License Information
-
More Information
Article History
Received: 29 August 2024
Accepted: 17 March 2025
First Online: 27 March 2025
Declarations
:
: This study was conducted in accordance with the principles outlined in the Declaration of Helsinki and was approved by the Ethics Committee of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Approval number: 22/444–3646). As this research involved a retrospective analysis of previously collected data, the requirement for informed consent was waived by the committee. The ethics committee also waived the need for consent to participate in the study. All data were de-identified to maintain patient confidentiality and privacy. The retrospective nature of the study ensured that there was no direct contact with patients, and no additional risks were posed to individuals whose data were included in the study.
: Not applicable.
: The authors declare no competing interests.
